These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20626904)

  • 1. Balancing medicine prices and business sustainability: analyses of pharmacy costs, revenues and profit shed light on retail medicine mark-ups in rural Kyrgyzstan.
    Waning B; Maddix J; Soucy L
    BMC Health Serv Res; 2010 Jul; 10():205. PubMed ID: 20626904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards equitable access to medicines for the rural poor: analyses of insurance claims reveal rural pharmacy initiative triggers price competition in Kyrgyzstan.
    Waning B; Maddix J; Tripodis Y; Laing R; Leufkens HG; Gokhale M
    Int J Equity Health; 2009 Dec; 8():43. PubMed ID: 20003422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retail pharmacy prescription medicines' availability, prices and affordability in Eswatini.
    Shambira G; Suleman F
    Afr J Prim Health Care Fam Med; 2021 Sep; 13(1):e1-e11. PubMed ID: 34636605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affordable and equitable access to subsidised outpatient medicines? Analysis of co-payments under the Additional Drug Package in Kyrgyzstan.
    Vogler S; Schneider P; Dedet G; Bak Pedersen H
    Int J Equity Health; 2019 Jun; 18(1):89. PubMed ID: 31196109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Availability, prices and affordability of essential medicines for treatment of diabetes and hypertension in private pharmacies in Zambia.
    Kaiser AH; Hehman L; Forsberg BC; Simangolwa WM; Sundewall J
    PLoS One; 2019; 14(12):e0226169. PubMed ID: 31834889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia.
    Babar ZU; Ibrahim MI; Singh H; Bukahri NI; Creese A
    PLoS Med; 2007 Mar; 4(3):e82. PubMed ID: 17388660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflated medicine prices in Vietnam: a qualitative study.
    Nguyen TA; Knight R; Mant A; Razee H; Brooks G; Dang TH; Roughead EE
    Health Policy Plan; 2017 Jun; 32(5):647-656. PubMed ID: 28453716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gross profits of Canadian pharmacies: A changing policy regime.
    Thanh NX; Jacobs P; Husereau D
    Healthc Manage Forum; 2020 Sep; 33(5):228-232. PubMed ID: 32552055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis.
    Cameron A; Ewen M; Ross-Degnan D; Ball D; Laing R
    Lancet; 2009 Jan; 373(9659):240-9. PubMed ID: 19042012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuing effects of Medicare Part D on rural independent pharmacies who are the sole retail provider in their community.
    Radford A; Mason M; Richardson I; Rutledge S; Poley S; Mueller K; Slifkin R
    Res Social Adm Pharm; 2009 Mar; 5(1):17-30. PubMed ID: 19285286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Availability, price and affordability of essential medicines for managing cardiovascular diseases and diabetes: a statewide survey in Kerala, India.
    Satheesh G; Sharma A; Puthean S; Ansil T P M; E J; Raj Mishra S; Unnikrishnan MK
    Trop Med Int Health; 2020 Dec; 25(12):1467-1479. PubMed ID: 32959441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
    Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D
    Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicine prices in urban Mozambique: a public health and economic study of pharmaceutical markets and price determinants in low-income settings.
    Russo G; McPake B
    Health Policy Plan; 2010 Jan; 25(1):70-84. PubMed ID: 19843636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access and Affordability of Medicines in Malaysia: Need for a National Pricing Policy.
    Wong SL; Ibrahim S; Abdul Kadir N; Mohd Salleh S
    Appl Health Econ Health Policy; 2019 Oct; 17(5):641-654. PubMed ID: 31093937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prices people pay for medicines in Zimbabwe.
    Gavaza P; Simoyi T; Makunike B; Maponga CC
    Cent Afr J Med; 2009; 55(1-4):14-9. PubMed ID: 21977842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 340b Program, Contract Pharmacies, Hospitals, and Patients: An Evolving Relationship Impacting Health Care Delivery.
    Ruley M; Belcher M; Sayre H; Coustasse A
    Health Care Manag (Frederick); 2019; 38(4):311-321. PubMed ID: 31663869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term differences in drug prices after implementation of the national essential medicines system: A case study in rural Jiangxi Province, China.
    Wang J; Liu X; Wang S; Chen H; Wang X; Zhou W; Wang L; Zhu Y; Zheng X; Hao M
    Indian J Pharmacol; 2015; 47(5):535-9. PubMed ID: 26600644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation of prescription drug prices in community pharmacies: A national cross-sectional study.
    Larkin J; Moriarty F; McGuinness S; Finucane K; Fitzgerald K; Smith SM; O'Mahony JF
    Res Social Adm Pharm; 2022 Oct; 18(10):3736-3743. PubMed ID: 35618647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competition in the German pharmacy market: an empirical analysis.
    Heinsohn JG; Flessa S
    BMC Health Serv Res; 2013 Oct; 13():407. PubMed ID: 24112461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.